Analysis Reveals Surge in Gambling Disorder Diagnoses Following Sports Betting Legalization

A recent Sports Business Journal review of medical claims data has drawn attention to shifts in gambling disorder diagnoses across the United States, and the patterns align closely with the rollout of legalized sports betting. The analysis examined records from multiple states and found diagnoses increased more than 60 percent in places where sports betting became legal, while they declined 29 percent in states that maintained prohibitions. These figures emerged in a June 2026 report that compared pre- and post-legalization periods, and observers note the timing coincides with expanded access through mobile apps and widespread advertising campaigns. The absolute numbers stay modest even after the increases. Legalized states recorded 4.8 diagnoses per 100,000 residents, whereas non-legalized states showed 2.2 per 100,000. Still, the relative jump stands out because it reverses a downward trend that had been visible in states without betting markets. Researchers tracked the data through insurance claims and clinical encounters, which means the numbers reflect only those individuals who sought formal medical attention rather than the full scope of gambling-related issues.

Age Group Patterns Stand Out in the Data

The sharpest rise appeared among adults aged 18 to 29, where diagnosis rates doubled in legalized states. That age bracket already showed higher baseline engagement with mobile betting platforms, and the analysis indicates the availability of instant deposits and live-odds features may have accelerated exposure. In contrast, older age groups displayed smaller percentage changes, although they still contributed to the overall statewide increase. Public health researchers have pointed out that younger adults often encounter sports betting advertisements during live game broadcasts, which creates repeated prompts throughout an evening of viewing.

States without legalized sports betting experienced the 29 percent drop across all adult demographics, and the decline continued a trajectory that predated the national expansion of betting markets. Analysts attribute part of that reduction to sustained public awareness campaigns and tighter restrictions on gambling advertising in those jurisdictions. The divergence between the two groups of states becomes more noticeable when the data is segmented by year of legalization, because states that approved betting earlier show larger cumulative increases.

Access and Advertising Factors Examined

The report links the diagnosis trends to greater physical and digital availability of betting products once legalization occurs. Mobile apps allow users to place wagers from any location with an internet connection, and many operators offer sign-up bonuses that reduce the initial financial barrier. Advertising spend on sports betting has grown in tandem with legalization, and the analysis notes that states with the highest volume of television and digital ads also posted the largest diagnosis increases. One study revealed that exposure frequency correlates with help-seeking behavior, particularly when advertisements appear during high-profile sporting events that draw large young adult audiences.

Yet the low overall rates suggest most bettors do not progress to a diagnosable disorder. The data therefore serves as an early indicator rather than evidence of widespread harm. Medical coding practices can also influence counts, because providers must document a gambling disorder specifically for insurance reimbursement, and awareness among clinicians has risen in recent years. The analysis adjusted for these variables by comparing trends within the same health systems before and after legalization dates.

State-by-State Variations Provide Additional Context

Individual state results varied around the national averages. Some early-adopter states recorded increases exceeding 70 percent, whereas more recent adopters showed rises closer to 50 percent. Non-legalized states maintained steady downward trajectories, and a handful posted reductions greater than 35 percent. The consistency of the split between the two categories strengthens the association between legalization and diagnosis changes, although the report stops short of claiming direct causation. Factors such as population density, existing casino infrastructure, and socioeconomic conditions were considered as potential confounders, yet the legalization variable remained the strongest predictor in the models.

Public health departments in several legalized states have begun reviewing the findings to determine whether additional responsible-gambling measures might be warranted. These steps include mandatory spending limits within apps, reality-check notifications, and targeted outreach to younger users. The analysis supplies a baseline that future studies can use when evaluating the effectiveness of such interventions.

Conclusion

The Sports Business Journal review supplies one of the first multi-state comparisons that isolates the effect of sports betting legalization on clinically documented gambling disorders. While absolute rates remain low, the more than 60 percent rise in legalized jurisdictions and the doubling among 18-to-29-year-olds highlight a measurable shift that coincides with expanded access and advertising. States that have not legalized sports betting continue to show declining diagnoses, which offers a contrasting data point for policymakers weighing regulatory choices. Continued monitoring through claims data will allow researchers to track whether these patterns stabilize or accelerate as markets mature.